(CURRICULUM VITAE)

Gregg L. Mayer, Ph.D.
Gregg L. Mayer & Company, Inc.
7019 Stockton Avenue
El Cerrito, CA  94530   USA
Tel: 1-510-559-3200
Fax: 1-510-559-4044
e-mail: gregg@glmco.com

EDUCATION	B.A., Biology 1981 Ph.D., Physiology 1987 UNIVERSITY OF CALIFORNIA, BERKELEY
RESEARCH	Ph.D. dissertation research focused on the structure/function relationships of protein hormones
BUSINESS EXPERIENCE	BERKELEY ANTIBODY COMPANY, INC. (BAbCO), Berkeley, California: a biotechnology company producing monoclonal and polyclonal antibodies, now a subsidiary of Covance, Inc.
1981-1983	Co-founder and Partner
1983-1986	President and Director: The firm incorporated, raised seed capital, and expanded operations. Responsibilities included the direction of sales and marketing, in addition to general management. VIVIGEN, INC., Santa Fe, New Mexico: a clinical genetic testing company, serving physicians, hospitals, and HMOs nationwide. In late 1992, Vivigen became a subsidiary of Genzyme Corporation.
1985-1992	Director
1986-1987	Vice President: Responsibilities included the investigation of new technologies for potential business opportunities
1988-1990	President: Responsibilities included the direction of sales and marketing in addition to general management.  In 1988 and 1989, Vivigen was named one of "The Best Small Growth Companies in America" by Business Week magazine.
	MCKINSEY & COMPANY,  San Francisco, California: an international management consulting firm.
1993-1995	Associate: Two years of healthcare consulting projects included developing a strategy for an academic medical center in an increasingly competitive managed care environment, developing a national sales accounts program for an HMO, and reengineering of primary care delivery in a regional HMO. SCIENCE AND TECHNOLOGY CORPORATION @ UNM, Albuquerque, NM: a private, non-profit company formed by the University of New Mexico to commercialize university technology.
1994-	Director GREGG L. MAYER & COMPANY, INC.,  El Cerrito, California: a healthcare management consulting firm, serving pharmaceutical, biotechnology, medical device, and managed care companies in the U.S. and Japan.
1995-	President & CEO KAISER PERMANENTE INTERNATIONAL, Oakland, California:  The international subsidiary of the largest HMO in America
1996-1998	Director – Japan PROACTIVE HEALTHCARE TOOLS, INC., El Cerrito, California: A health management organization start-up
2000-	Founder & CEO DISEASE MANAGEMENT ASSOCIATION OF JAPAN, a Japanese industry association studying and promoting the disease prevention and management industry in Japan; founded in 2005.
2005-	Director (the only non-Japanese Director)   JAPAN SOCIETY FOR HEALTH SUPPORT SCIENCES, a new academic society promoting the research and development of effective disease management and prevention programs in Japan; founded in 2006. A peer-reviewed journal will be published beginning in 2007.
2006-	Director (the only non-Japanese Director)
STUDIES IN JAPAN
1990-1992	Student at Keio University, Tokyo in the Japanese language program.
1991-1993	Research student at The Keio University Graduate School of Business Administration.  Research topics included the Japanese business environment and health care economics.
1992-1994	Research student at the National Children's Hospital Research Center in Tokyo.  Research topics include the Japanese healthcare system and the practice of clinical genetics in Japan.

 

CURRENT INTERESTS AND PROJECT THEMES

• International technology transfer and business development strategies
• Comparative health care between the US and Japan
• Biotechnology
• Disease management and prevention
• Innovations in health care delivery and financing
• Entrepreneurial business ventures in health care
• Health care information systems

SELECTED PUBLICATIONS (all in English unless noted)

• “Information Therapy: New Patient-Centric Information Tools Deliver in Today’s Integrated Healthcare”, Gregg L. Mayer, Healthcare Network Management (Elsevier) October, 2005, 1(2):92-95. (Japanese)
• “The Paradigm Shift Towards Patient Centered Integration in US Health Care Systems”, Gregg L. Mayer, Healthcare Network Management (Elsevier) June, 2005, 1(1):93-95. (Japanese)
•  “Applications of Disease Management in a Variety of Settings Worldwide (2)”, Gregg L. Mayer and Hiroyuki Sakamaki, New Medical World Weekly no. 2592, July 12, 2004. (Japanese)
• “Applications of Disease Management in a Variety of Settings Worldwide (1)”, Gregg L. Mayer and Hiroyuki Sakamaki, New Medical World Weekly  no. 2588, June 14, 2004, (Japanese)
• “The Use of Pharmacoeconomics in the US Healthcare System”, Gregg L. Mayer, Hakugi Kiyono and Hiroyuki Sakamaki, Japanese Journal of Health Economics and Policy Vol. 14:41-70, 2004
• Editorial Board Member since 2004, Disease Management Reporter in Japan, a quarterly newsletter published by the Sompo Japan Research Institute, Inc. (Japanese and English)
• “A Snapshot of e-Healthcare in the US and Implications for its Development in Japan”, Gregg L. Mayer, Nicola Alesandrini, Hakugi Kiyono and Hiroyuki Sakamaki, Japanese Journal of Health Economics and Policy Vol. 12: 43-63, 2002
• “The Current State of Disease Management in the US”, Shigeru Tanaka and Gregg L. Mayer, Health Insurance 56(12):34-42, 2002 (in Japanese)
• “Health Care System Innovations in the Managed Care Era in the US”, Gregg L. Mayer and Shigeru Tanaka, Keio Business Forum: Special Issue for Managed Care 17(2): 19-37, 1999
• “The Changing Role of The Primary Care Physician In Managed Care”, Gregg L. Mayer and Shigeru Tanaka, Journal of Health Care and Society 8(4):41-52, 1999
• “Venture: A Case Report on the Industrialization of Autologous Chondrocyte Implantation in the United States”, Michiaki Morohashi, Gary C. DuMoulin, Leesa M. Barone, and Gregg L. Mayer, Journal of Tissue Culture and Engineering 23(14):40-43, 1997 (in Japanese)
• “Managed Care Development and Innovations in the US and Their Policy Implications for Japan”, Gregg L. Mayer and Shigeru Tanaka, Journal of Health Care and Society 7(1):109-127, 1997

 

SELECTED LECTURES IN JAPAN (all in Japanese unless noted)

• “A Brief Introduction to Medicare, and Comparison to Japan’s National Health Insurance System, The Disease Management Policy Issues Study Forum Symposium, “How To Address The Problems Of Lifestyle-Related Diseases: A Look At The Pilot Disease Management Programs Introduced Into The Medicare System.  Sponsored by the Ministry of Health Labor and Welfare, Japan Hospital Association, and the National Federation of Health Insurance Societies, and supported by Sompo Japan Research Institute. Tokyo, Japan, January 27, 2006.
• “What is Disease Management?” Disease Management Association of Japan Inaugural Meeting, Tokyo, Japan, June 4, 2005, Tokyo, Japan
• “Disease Management and Its Application to Japan: 2005 Update”, Presentation to the Disease Management Association of Japan predecessor study group Tokyo, Japan, March 21, 2005
• “Disease Management: Current Snapshot and Potential for Application to Japan”, Presentation to the Disease Management Association of Japan predecessor study group. Tokyo, Japan, March 5, 2004
• “Disease Management in the US today: Helping the Chronically Ill Live Better Through Empowerment and Support”, Comparative US/European Healthcare Business and Disease Management Research Group Symposium: Potential for Disease Management Development and Issues for its Application to Japan. Sponsored by the Ministry of Health Labor and Welfare, Japan Medical Association, and the National Federation of Health Insurance Societies, and supported by Sompo Japan Research Institute.  Tokyo, Japan, November 21, 2003
• “Disease Management in the US: Update and Application to Japan”, National Federation of Health Insurance Societies Seminar, Tokyo Japan, July 24, 2002
• “Diabetes DM:  From EBM to ROI”, Yasuda Research Institute Disease Management Study Group, Tokyo, Japan, July 22, 2002
•  “Opportunities for Tissue Engineering/Regenerative Medicine Companies and Products in Japan”, Kansai BioConference in Kobe, Kobe, Japan, March 13, 2002
• “Disease Management in the US: Measuring Value of Disease Management Programs” Yasuda Research Institute Disease Management Study Group, Tokyo, Japan, February 13, 2002
• “Disease Management in the US: Innovations and Results in Disease Management by Private Industry”, Yasuda Research Institute Disease Management Study Group, Tokyo, Japan, September 25, 2001
• “Healthcare Industry in the US and Japan:  Comparison and Future Outlook”, Morningstar Mutual Fund Conference, Tokyo Japan, March 18, 2001
•  “Biotechnology Industry in the US and Japan:  Comparison and Future Outlook”, Keio University Graduate School of Business Administration, Guest Lecturer in the Japanese Business Environment Class (English language), Hiyoshi, Japan, March 14, 2001
• “Telemedicine in Asthma Disease Management in the US”, 50th Anniversary Meeting of the Japan Allergy Society, Yokohama, Japan, November 30, 2000
• “Disease Management: an Update on Recent Activity in the US”, 50th Anniversary Meeting of the Japan Hospital Association, Akita, Japan, June 2000
• “”Health Care System Innovations in the Managed Care Era in America”, Keio University Managed Care Seminar, Tokyo, Japan, February 1999
• “Managed Care in the US and its Policy Implications for Japan”, Pharma Delegates Meeting, Tokyo, Japan, January, 1998